Waverley Pharma Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Waverley Pharma Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CAD 353,305 compared to CAD 264,290 a year ago. Net income was CAD 989 compared to net loss of CAD 480,298 a year ago. Basic eps - continuing operations was CAD 0 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. For the nine months, sales was CAD 949,521 compared to CAD 884,852 a year ago. Net loss was CAD 383,609 compared to CAD 882,568 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.